Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -2.658\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CC(C)(C)C#CCn1c(/C=[N+](\[O-])C2CCCCC2)nc2ccccc21
b: Cc1sc(NC(=O)c2ccco2)c(C(c2cccnc2)N2CCN(CCO)CC2)c1C
Answer: a. CC(C)(C)C#CCn1c(/C=[N+](\[O-])C2CCCCC2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(C)C#CCn1c(/C=[N+](\[O-])C2CCCCC2)nc2ccccc21
CC(C)(C)C#CCn1c(/C=[N+](\[O-])C2CCCCC2)nc2ccccc21
N-cyclohexyl-1-[1-(4,4-dimethylpent-2-ynyl)benzimidazol-2-yl]methanimine oxide